Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome.
EFSA Panel on Plant Protection Products and their Residues (PPR); Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Angeli K, Recordati C, Van Durseen M, Aiassa E, Lanzoni A, Lostia A, Martino L, Guajardo IPM, Panzarea M, Terron A, Marinovich M.
EFSA Panel on Plant Protection Products and their Residues (PPR), et al. Among authors: marinovich m.
EFSA J. 2023 Feb 14;21(2):e07744. doi: 10.2903/j.efsa.2023.7744. eCollection 2023 Feb.
EFSA J. 2023.
PMID: 36818642
Free PMC article.